Cyclooxygenase (COX)-2 oxygenates arachidonic acid (AA) and 2-arachidonylglycerol (2-AG) to endoperoxides, which are subsequently transformed to prostaglandins (PGs) and glycerylprostaglandins (PG-Gs). PG-G formation has not been demonstrated in intact cells treated with a physiological agonist. Resident peritoneal macrophages, which express COX-1, were pretreated with lipopolysaccharide to induce COX-2. Addition of zymosan caused release of 2-AG and production of the glyceryl esters of PGE 2 and PGI 2 over 60 min. The total quantity of PG-Gs (16 ؎ 6 pmol/10 7 cells) was much lower than that of the corresponding PGs produced from AA (21,000 ؎ 7,000 pmol/10 7 cells). The differences in PG-G and PG production were partially explained by differences in the amounts of 2-AG and AA released in response to zymosan. The selective COX-2 inhibitor, SC236, reduced PG-G and PG production by 49 and 17%, respectively, indicating a significant role for COX-1 in PG-G and especially PG synthesis. Time course studies indicated that COX-2-dependent oxygenation rapidly declined 20 min after zymosan addition. When exogenous 2-AG was added to macrophages, a substantial portion was hydrolyzed to AA and converted to PGs; 1 M 2-AG yielded 820 ؎ 200 pmol of PGs/10 7 cells and 78 ؎ 41 pmol of PG-Gs/10 7 cells. SC236 reduced PG-G and PG production from exogenous 2-AG by 88 and 76%, respectively, indicating a more significant role for COX-2 in the utilization of exogenous substrate. In conclusion, lipopolysaccharide-pretreated macrophages produce PG-Gs from endogenous 2-AG during zymosan phagocytosis, but PG-G formation is limited by substrate hydrolysis and inactivation of COX-2.Cyclooxygenase (COX 1 ; prostaglandin G/H synthase) catalyzes the first two steps in the conversion of arachidonic acid (AA) to prostaglandins (PG), prostacyclin, and thromboxane (1-4). The product of the COX reaction is the endoperoxide, PGH 2 , which is then further metabolized to the terminal PGs through the action of various synthase enzymes. Two isoforms of COX have been identified and characterized (5). The isoforms differ considerably with regard to transcriptional regulation in that COX-1 is usually expressed constitutively, whereas COX-2 is induced in response to a variety of inflammatory and proliferative stimuli, including cytokines, growth factors, and tumor promoters. As a consequence of these varied expression patterns, COX-1 is believed to be primarily responsible for "housekeeping" functions such as gastric cytoprotection and regulation of platelet aggregation. In contrast, COX-2 is thought to be involved in the inflammatory response, pyrexia, and in the regulation of cellular proliferation (6 -11). However, recent work has indicated that these distinct roles are probably oversimplified, leaving an ongoing question as to the exact physiological functions of each isoform (12).Despite their differences in transcriptional regulation, COX-1 and COX-2 share 60% sequence identity, with nearly superimposable three-dimensional structures and highly similar ...